We tested the hypothesis that an increased epithelial permeability may affect sites other than the intestine in patients with Crohn's disease by simultaneously evaluating their pulmonary and intestinal permeability. Pulmonary and intestinal permeability were measured by clearance of inhaled technetium99m diethylene triamine pentacetate (99mTc-DTPA) and by urinary recovery of chromium-51 ethylene diamine tetracetate respectively in 22 patients with Crohn's disease. The half time clearance of 99mTc-DTPA from lung to-blood
clearance of 99mTc-DTPA from lung to-blood (t½/2LB) was decreased -that is pulmonary permeability increased -in the whole group of patients with Crohn's disease as compared with (8.1% (1.6-24) and 3.5% (1.2.9.2) v 1.7% (0.65-5.75)) (p<0.0001, p=0.05 respectively). Six patients with active Crohn's disease were studied again when their disease was quiescent and their intestinal permeability decreased significantly p<004). Pulmonary permeability was increased in patients with Crohn's disease but was not greatly influenced by Crohn's disease activity as opposed to intestinal permeability. The mechanism of this increase is unknown, but may be related in some patients to the presence of an alveolitis.
The aetiology of Crohn's disease remains unknown despite intensive research efforts. The current concept of the pathogenesis of Crohn's disease includes interactions between immunological abnormalities, environmental agents, and genetic influences.' Increased intestinal permeability to luminal antigens could be one of the aetiologic factors.45 Indeed, increased intestinal permeability has been described in Crohn's disease using various probes.5 ' After correction for radionuclide decay, the activity measured was plotted versus time. A monoexponential fitting was carried out on the curve between the peak activity and the 10 minute point after the peak activity. This exponential curve allowed calculation of the half-time clearance -that is, the time for a 50% decrease from the peak activityof 99mTc-DTPA from lung to blood (t/2LB) expressed in minutes. The estimated radiation dose was smaller than 0-2 mGy to the whole body and 0-2 mGy to the gonads.
MEASUREMENT OF INTESTINAL 51Cr-EDTA CLEARANCE
Intestinal permeability was assessed using 5 Cr labelled with ethylenediaminetetra acetic acid (EDTA) according to Bjarnason's technique.8
After an overnight fast, 3-7 MBq (100 [tCi) 51Cr-EDTA (specific activity: 17 to 75 MBq/mg, International CIS) was given orally and followed with 125 ml of water. Urine was collected during 24 hours. Two hours after they drank the 51Cr-EDTA solution, subjects were allowed normal food and fluid intake, except for alcohol. Three 5 ml samples of the pooled 24 hour urine collection were counted together with a 5 ml sample of a 1:5000 dilution of the oral dose in a gamma counting system equipped with a NaI crystal (Gammamatic I, Kontron). Radioactivity excreted in the urine over the 24 hour period was expressed as the percentage of the total oral dose. The estimated delivered radiation dose was smaller than 0.05 mGy to the whole body and 0.2 mGy to the gonads. Table II . One patient (patient 1) with normal pulmonary permeability had normal bronchoalveolar lavage values. Five patients of six had an increased pulmonary permeability -that is, t/2LB <58.3%
(mean-SD of controls); four of these five had abnormal bronchoalveolar lavage values, including one neutrophilic alveolitis (patient 4), two lymphocytic alveolitis (patients 3 and 6), and one associated lymphocytic and neutrophilic alveolitis (patient 2). Finally all patients with abnormal bronchoalveolar lavage values had an increased pulmonary permeability.
Discussion
Using measurement of pulmonary 99mTc-DTPA clearance, we have shown that pulmonary permeability was significantly increased in Crohn's disease as a whole. Our technique has previously allowed to detect an abnormally raised pulmonary permeability in patients who were cigarette smokers30 and in patients with interstitial lung disease.2"2531 32 In contrast, intestinal permeability was increased in Crohn's disease but decreased with the disease activity as previously described. 1 113 33 Those results are not in accordance with Robertson et a134 who reported that patients with inflammatory bowel disease had normal pulmonary permeability as compared with healthy controls. This difference might be because in Robertson's study, pulmonary permeability was measured in a whole group of patients with inflammatory bowel disease (not distinguishing between Crohn's disease and ulcerative colitis) whereas our study only deals with patients with Crohn's disease.
The relationship between pulmonary permeability and Crohn's disease activity is not yet clearly elucidated. On one hand when patients with active and inactive disease were compared with controls, it was only those with active Crohn's disease that have We would like to acknowledge the assistance of Dr J C Paris, R Collet and Dr X Lesage who incorporated patients in this study. permeability in Crohn's disease. 
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